Sulfur mustard is cytotoxic to dermal ®broblasts as well as epidermal keratinocytes. We demonstrated that poly(ADP-ribose) polymerase (PARP) modulates Fas-mediated apoptosis, and other groups and we have shown that PARP plays a role in the modulation of other types of apoptotic and necrotic cell death. We have now utilized primary dermal ®bro-blasts, immortalized ®broblasts, and keratinocytes derived from PARP ±/± mice and their wildtype littermates (PARP +/+ ) to determine the contribution of PARP to sulfur mustard toxicity. Following sulfur mustard exposure, primary skin ®broblasts from PARP-de®cient mice demonstrated increased internucleosomal DNA cleavage, caspase-3 processing and activity, and annexin V positivity, compared to those derived from PARP +/+ animals. Conversely, propidium iodide staining, PARP cleavage patterns, and random DNA fragmentation revealed a dosedependent increase in necrosis in PARP +/+ but not PARP ±/± cells. Using immortalized PARP ±/± ®bro-blasts stably transfected with the human PARP cDNA or with empty vector alone, we show that PARP inhibits markers of apoptosis in these cells as well. Finally, primary keratinocytes were derived from newborn PARP +/+ and PARP ±/± mice and immortalized with the E6 and E7 genes of human papilloma virus. In contrast to ®broblasts, keratinocytes from both PARP ±/± and PARP +/+ mice express markers of apoptosis in response to sulfur mustard exposure. The effects of PARP on the mode of cell death in different skin cell types may determine the severity of vesication in vivo, and thus have implications for the design of PARP inhibitors to reduce sulfur mustard pathology. Key words: caspase-3/ poly(ADP-ribose) polymerase/sulfur mustard. J Invest Dermatol 117: 1566±1573, 2001 S ulfur mustard [bis-(2-chloroethyl) sul®de; SM] causes blisters in the skin via poorly understood mechanisms. We have previously shown that SM induces markers of terminal differentiation and apoptosis in normal human epidermal keratinocytes . In addition to the direct effect of SM on keratinocytes, dermal ®broblasts are important for the vesication response. Human dermal ®broblasts may contribute to the vesication response by releasing degradative cytosolic components extracellularly after SM exposure. Lactate dehydrogenase, a cytosolic marker of necrotic cell death, was shown to be released in a time-dependent fashion after exposure of a dermal equivalent to 2 mM SM, suggesting a steady leakage of cytosolic constituents after the initial exposure. Elastase levels also increased to over 740% of those in control culture medium 24 h after exposure (Lindsay and Upshall, 1995) . In another study, SM was shown to produce both dose-and timedependent cytotoxicity of a dermal equivalent, and a decreased synthesis of ®bronectin by dermal ®broblasts. These SM-induced dermal alterations were correlated with secondary modi®cations of epithelial adhesion and maturation of unexposed normal human keratinocytes (Gentilhomme et al, 1998) . We have also shown decreased levels of ®bronectin in normal human epidermal keratinocytes exposed to SM . In 3T3 ®broblasts, total protein synthesis was reduced to < 20% of controls 24 h after SM exposure (Detheux et al, 1997) . Cell viability was not strongly affected, although the SM was used at a concentration of only 100 mM, corresponding to the lowest dose we used in this study.
S ulfur mustard [bis-(2-chloroethyl) sul®de; SM] causes blisters in the skin via poorly understood mechanisms. We have previously shown that SM induces markers of terminal differentiation and apoptosis in normal human epidermal keratinocytes . In addition to the direct effect of SM on keratinocytes, dermal ®broblasts are important for the vesication response. Human dermal ®broblasts may contribute to the vesication response by releasing degradative cytosolic components extracellularly after SM exposure. Lactate dehydrogenase, a cytosolic marker of necrotic cell death, was shown to be released in a time-dependent fashion after exposure of a dermal equivalent to 2 mM SM, suggesting a steady leakage of cytosolic constituents after the initial exposure. Elastase levels also increased to over 740% of those in control culture medium 24 h after exposure (Lindsay and Upshall, 1995) . In another study, SM was shown to produce both dose-and timedependent cytotoxicity of a dermal equivalent, and a decreased synthesis of ®bronectin by dermal ®broblasts. These SM-induced dermal alterations were correlated with secondary modi®cations of epithelial adhesion and maturation of unexposed normal human keratinocytes (Gentilhomme et al, 1998) . We have also shown decreased levels of ®bronectin in normal human epidermal keratinocytes exposed to SM . In 3T3 ®broblasts, total protein synthesis was reduced to < 20% of controls 24 h after SM exposure (Detheux et al, 1997) . Cell viability was not strongly affected, although the SM was used at a concentration of only 100 mM, corresponding to the lowest dose we used in this study.
As SM is a strong alkylating agent, its ability to induce DNA damage via apurinic sites and endonucleolytic cleavage has been advanced as one possible pathway leading to cell death and vesication (Papirmeister et al, 1985) . SM has in fact been shown to induce DNA breaks in cultured cells and activate the nuclear protein poly(ADP-ribose) polymerase (PARP) within 2 h of exposure Hinshaw et al, 1999) . Similar to other agents that induce DNA strand breakage, SM-induced PARP activation results in the poly(ADP-ribosyl)ation of a number of nuclear proteins using nicotinamide adenine dinucleotide (NAD) as a substrate. We have shown that topical SM exposure induces poly(ADP-ribosyl)ation of nuclear proteins in skin grafts derived from control human keratinocytes, but not those stably transfected with a PARP antisense inducible vector (Rosenthal et al, 1995) . A role of PARP in SM-mediated cell death has also been investigated in peripheral blood lymphocytes, where PARP inhibitors have been shown to extend the lifespan of cells treated with SM (Meier and Johnson, 1992; Meier, 1996) .
The mechanisms by which PARP may modulate SM-induced cytotoxicity and vesication are unknown. PARP has been implicated as an important regulator of both apoptosis and necrosis, however. Induction of PARP can drastically deplete levels of cellular NAD and adenosine triphosphate (ATP) (Wielckens et al, 1982; Alvarez et al, 1986) , and the potential role for PARP in cell death via this mechanism was ®rst proposed by Berger et al (1983; Berger, 1985) . Partial depletion of ATP by other agents has also been shown to induce apoptosis of cultured renal epithelial cells (Feldenberg et al, 1999) . Further depletion of ATP below a threshold level might be expected to inhibit the later events in apoptosis, depending on the cell type and inducing agent. For instance, Fas-induced apoptosis is completely blocked by reducing intracellular ATP levels (Eguchi et al, 1999) . In some cells, this may re¯ect the requirement for dATP/ATP in the activation of caspase-9 (Hu et al, 1999; Saleh et al, 1999; Zou et al, 1999) . Proteolytic cleavage of PARP was ®rst demonstrated in chemotherapyinduced apoptosis (Kaufmann et al, 1993) , and the speci®c proteolysis of PARP is now closely associated with apoptosis in different systems (Neamati et al, 1995; Nicholson et al, 1995; Tewari et al, 1995) . Cleavage of PARP at later stages of apoptosis would prevent ATP from falling below this critical level. Consistent with this idea, it was found that PARP inhibitors prevent the SM-induced expression of necrotic markers in lymphocytes (Meier and Millard, 1998) .
Thus, the cellular response to DNA damaging agents such as SM may depend upon the level and type of damage, as well as the cell type. In less severely damaged cells, PARP may signal a repair response and protect against deleterious DNA recombination (Chatterjee et al, 1999) . In more severely damaged cells, PARP activation induces poly(ADP-ribosyl)ation of key nuclear proteins, including p53 (Whitacre et al, 1995; Simbulan-Rosenthal et al, 1999) , and a concomitant lowering of NAD and ATP levels, resulting ultimately in cell death, the form of which (apoptosis versus necrosis) may depend upon a number of factors, including the time of onset of caspase activation and proteolytic cleavage of PARP.
The PARP homozygous knockout mouse (PARP ±/± ) model has been a powerful tool to analyze the roles of PARP in cell death induced by different agents both in cultured cells and intact animals. PARP ±/± mice have now been independently generated from the interruption of exon 2 (Wang et al, 1995 ), exon 4 (de Murcia et al, 1997 , and, most recently, exon 1 (Masutani et al, 1999) of the PARP gene on chromosome 1 (PARP-1). PARP ±/± mice neither express intact PARP nor exhibit signi®cant poly(ADP-ribosyl)ation (Wang et al, 1995; de Murcia et al, 1997; Masutani et al, 1999) . Both exon 1 (Masutani et al, 1999) and exon 2 (Burkart et al, 1999; Pieper et al, 1999) PARP ±/± animals have been shown to be resistant to streptozotocin-induced pancreatic islet cell death, associated with NAD depletion in PARP +/+ animals. We have also collaborated in a study that demonstrated that exon 2 PARP ±/± animals are resistant to the neurotoxin MPTP-induced parkinsonism (Mandir et al, 1999) . Exon 2 PARP ±/± animals are also more resistant to ischemic injury (Eliasson et al, 1997; Endres et al, 1997; Szabo et al, 1997; Zingarelli et al, 1999) . In exon 2 PARP ±/± cell culture, the apoptotic response to Fas plus cycloheximide is altered, and stable transfection of PARP cDNA reverts these cells to a response similar to that of PARP +/+ cells . Further, expression of caspase-3-resistant PARP in exon 2 PARP ±/± cells (Boulares et al, 1999; Herceg and Wang, 1999) , as well as expression of exogenous wildtype PARP (Boulares et al, 1999) in osteosarcoma cells, results in an earlier onset of both the apoptotic (Boulares et al, 1999; Herceg and Wang, 1999) and necrotic (Herceg and Wang, 1999) responses, a ®nding that is consistent with an active role for PARP and poly(ADP-ribosyl)ation early in apoptosis as well as necrosis. Further evidence for a role of PARP in necrosis was determined in studies in which exon 2 PARP ±/± ®broblasts were found to be more resistant to necrosis and ATP depletion induced by the alkylating agent N-methyl-N¢-nitro-N-nitrosoguanidine (Ha and Snyder, 1999) . As yet, no studies have been published on the effects of SM on PARP ±/± versus PARP +/+ animals or cells derived from them. In this study, we have utilized different cell types derived from exon 2 PARP ±/± and PARP +/+ animals to determine the contribution of PARP to apoptosis or necrosis following exposure to SM. We found that PARP plays a role in cell death induced by SM in primary and immortalized ®broblasts by shifting the mode of cell death from apoptosis to necrosis. Keratinocytes, on the other hand, express markers of apoptosis in the presence or absence of a functional PARP-1 gene. These results indicate that (i) dermal ®broblasts and keratinocytes, which both contribute to SM vesication, undergo different mechanisms of cell death in response to SM, and (ii) PARP shifts the mode of cell death from apoptosis to necrosis in dermal ®broblasts. Therefore, inhibition of PARP may be of therapeutic value in the treatment of or prophylaxis against SM injury, as apoptotic cell death may prevent the release of in¯ammatory or degradative enzymes contributing to vesication or inhibition of healing of SM-induced wounds.
MATERIALS AND METHODS

Cells
Normal human epidermal keratinocytes were prepared from human foreskins as described previously (Sto Èppler et al, 1998) and maintained in serum-free medium (SFM; Life Technologies). Normal human epidermal keratinocytes were grown in 75 cm 2 tissue culturē asks to 60%±80% con¯uency, and then exposed to SM diluted in SFM to ®nal concentrations of 100 mM or 300 mM. Medium was not changed for the duration of the experiments. Primary ®broblasts were derived from newborn dermis as described previously (Yuspa et al, 1981) . Newborn mouse keratinocytes were derived as described previously (Yuspa et al, 1981; Rosenthal et al, 1991) , and immortalized utilizing the E6/E7 genes of human papilloma virus 16 (HPV 16) (Sherman and Schlegel, 1996) in the LXSN retroviral vector (Clontech, Palo Alto, CA) as described previously (Sto Èppler et al, 1998) . Retrovirus-infected cells were selected in G418, and resistant clones were passaged and analyzed for the expression of keratins and the absence of vimentin utilizing the antipan cytokeratin (Sigma-Aldrich, St. Louis, MO) or antivimentin (Sigma-Aldrich) by both Western blot and immuno¯uorescent analysis.
Chemicals
SM (>98% purity) was obtained from the U.S. Army Edgewood Research, Development and Engineering Center.
Antibodies
Rabbit antiserum against the p17 subunit of caspase-3 was obtained from Donald Nicholson (Merck Frosst Center for Therapeutic Research, Montreal, Quebec, Canada). Rabbit antiserum recognizing both full-length PARP and the 89 kDa apoptotic cleavage product of PARP was a kind gift from Eric Ackerman (Paci®c Northwest National Laboratory, Richland, WA). Guinea pig antisera speci®c for poly(ADP-ribose) have been described previously (Rosenthal et al, 1995) . Antipan-keratin and antivimentin are from Sigma-Aldrich.
Immunoblot analysis
For immunoblot analysis, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) separated proteins were transferred to nitrocellulose ®lters. Proteins were measured (DCA protein assay; Bio-Rad, Hercules, CA) and normalized prior to gel loading, and all ®lters were stained with Ponceau-S, in order to reduce the possibility of loading artifacts. The details for using rabbit antiserum to human PARP (Ding et al, 1992) and guinea pig antiserum to poly(ADP-ribose) (Rosenthal et al, 1995) for immunoblot analysis have been described previously in detail. Immune complexes were visualized by electrochemiluminescence (Pierce, Rockford, IL).
Analysis of DNA fragmentation
Cells were harvested and lyzed in 0.5 ml of 7 M guanidine hydrochloride. The lysate was mixed with 1 ml of Wizard Miniprep resin (Promega, Madison, WI), incubated at room temperature for 15 min with occasional mixing, and then centrifuged at 10,000 Q g for 5 min. The resulting pellet was resuspended in 2 ml of washing solution [90 mM NaCl, 9 mM Tris-HCl (pH 7.4), 2.25 mM ethylenediamine tetraacetic acid (EDTA), 55% (vol/vol) ethanol] and drawn by vacuum through a Wizard Minicolumn (Promega) mounted onto a vacuum manifold. The column was washed twice with 4 ml of washing solution and dried by centrifugation over a microfuge tube at 10,000 Q g for 2 min. DNA was eluted from the column by adding 50 ml of deionized H 2 O, incubating at room temperature for 15 min, and then centrifuging at 10,000 Q g for 5 min. Residual RNA in the eluate was removed by incubation with 10 mg of RNase A (5 Prime-3 Prime, Boulder, CO) at 37°C for 30 min. DNA samples were loaded onto a 1.5% agarose gel in Tris-borate-EDTA buffer and subjected to electrophoresis at 4 V per cm. DNA ladders were visualized by staining with ethidium bromide (0.5 mg per ml) and images were captured with the Kodak EDAS 120 (Kodak) gel documentation system.
Annexin V and propidium iodide (PI) staining, and¯uorescence-activated cell sorter (FACS) analysis
Cells were plated in culture plates and exposed to SM. At the indicated times after induction of apoptosis, the cells were trypsinized, washed with ice-cold phosphatebuffered saline (PBS), and subsequently resuspended in and incubated in the dark with 100 ml of annexin V incubation reagent, which includes uorescein isothiocyanate (FITC) conjugated annexin V (Trevigen, Gaithersburg, MD) and PI for 15 min at room temperature. Flow cytometric analyses were conducted on a Becton-Dickinson FACStar Plus cytometer using a 100 mW air-cooled argon laser at 488 nm.
PARP cleavage assay
The full-length cDNA clone for PARP (pcD-12) (Alkhatib et al, 1987) was excised and ligated into the Xho I site of pBluescript-II SK+ (Stratagene, La Jolla, CA) and then used to drive the synthesis of PARP labeled with [ 35 S]methionine (Dupont-NEN, Boston, MA) by coupled T7 transcription/translation in a reticulocyte lysate system (Promega). [
35 S]PARP was separated from the other constituents by gel ®ltration chromatography on a Superdex-75 FPLC column (Pharmacia, Peapack, NJ; 1 Q 30 cm) in 10 mM HEPES/KOH (pH 7.4), 2 mM EDTA, 0.1% (wt/vol) CHAPS, and 5 mM dithiothreitol (DTT). Cytosolic extracts were prepared from normal human epidermal keratinocytes by scraping PBS-washed monolayers in 10 mM HEPES/KOH (pH 7.4), 2 mM EDTA, 0.1% CHAPS, 5 mM DTT, 1 mM phenylmethylsulfonyl¯uoride, 10 mg per ml pepstatin A, 20 mg per ml leupeptin, and 10 mg per ml aprotinin (at 1 Q 10 8 cells per ml). The post 100,000g supernatant was recovered after centrifugation. PARP cleavage activity was measured in mixtures containing 5 mg protein from the cytosol fractions of keratinocytes. Assay mixtures also contained puri®ed [ 35 S]PARP (»5 Q 10 4 cpm), 50 mM PIPES/KOH, 2 mM EDTA, 0.1% (wt/vol) CHAPS, and 5 mM DTT in a total volume of 25 ml. Incubations were performed at 37°C for 1 h, and terminated by the addition of 25 ml of 2 Q SDS-PAGE sample buffer containing 4% SDS, 4% b-mercaptoethanol, 10% glycerol, 0.125 M TrisHCl (pH 6.8), and 0.02% bromophenol blue. Samples were resolved by 10% SDS polyacrylamide gels. Either the PARP cleavage products were visualized by¯uorography, or the 89 kDa cleavage product of [ 35 S]PARP was quanti®ed relative to the full-length PARP using a Storm 840 PhosphorImage analyzer (Molecular Dynamics, Sunnyvale, CA). Quanti®cation included a correction for background, as well as for the difference in methionine residues present in the 89 kDa fragment (18 met residues) versus full-length PARP (25 met residues).
Assay of caspase-3 activity After harvesting, the cells were resuspended in Triton X-100 lysis buffer (60 mM Tris HCl, pH 7.5, 5 mM EDTA, 10% glycerol, 2 mM sodium orthovanadate, 25 mM sodium¯uoride, 10 mg per ml aprotinin, 10 mg per ml leupeptin, 1 mM AEBSF, 75 mM NaCl, 1 mg per ml pepstatin A, 1% Triton X-100) and incubated for 30 min at 4°C. The cell lysate was centrifuged at 14,000 Q g for 15 min and the supernatant containing the postnuclear extract was recovered. The protein concentration in the extract was determined using the Micro BCA protein assay kit (Pierce) and then the extract was stored at ±80°C until use. For the caspase-3 assay, 25 mg of extract was initially resuspended up to a volume of 50 ml with Triton X-100 lysis buffer, to which 50 ml of caspase assay buffer (10 mM HEPES, pH 7.4, 2 mM EDTA, 0.1% CHAPS, 5 mM DTT, 10 mg per ml aprotinin, 10 mg per ml leupeptin, 1 mM AEBSF, 1 mg per ml pepstatin A) was added. The aliquots were preincubated at 37°C for 30 min in a microtiter plate, and then mixed with an equal amount (100 ml) of 40 mM¯uorescent tetrapeptide substrate speci®c for caspase-3 (Ac-DEVD-AMC, Biomol, Plymouth Meeting, PA) in caspase assay buffer. The plate was read immediately. Free aminomethylcoumarin (AMC), generated as a result of cleavage of the aspartate±AMC bond, was monitored continuously over 10 min with a Cyto¯uor 4000¯uorometer (PerSeptive Biosystems, Framingham, MA) at excitation and emission wavelengths of 360 and 460 nm, respectively. The emission from each well was plotted against time, and linear regression analysis of the initial velocity (slope) for each curve yielded the activity.
RESULTS
SM induces PARP-dependent necrosis in primary skin ®broblasts We have previously shown that SM induces markers of terminal differentiation and apoptosis in normal human epidermal keratinocytes, including the early activation and late cleavage of PARP . In addition to the direct effect of SM on keratinocytes, ®broblasts are important for the vesication response (Lindsay and Upshall, 1995; Detheux et al, 1997; Gentilhomme et al, 1998) . We therefore ®rst derived primary skin ®broblasts from PARP ±/± and PARP +/+ animals. These ®broblasts were then exposed to three different doses of SM.
PARP undergoes proteolytic cleavage during chemotherapyinduced apoptosis (Kaufmann et al, 1993) . By immunoblot analysis with epitope-speci®c antibodies, it was demonstrated that programmed cell death was accompanied by early cleavage of PARP into 89 and 24 kDa fragments that contain the active site and the DNA-binding domain of the enzyme, respectively. We therefore determined whether cleavage of endogenous PARP could be Figure 1 . Exposure of primary dermal ®broblast cells derived from PARP ±/± but not PARP +/+ mice results in caspase-3 activation. Primary dermal ®broblasts were derived from newborn mice as described in Materials and Methods. Cells were incubated for 24 h (A, B) with the indicated concentrations of SM in keratinocyte growth medium, or for the indicated times with 100 mM SM (C), after which whole cell extracts were prepared and assayed for the presence of PARP by immunoblot analysis (A), or caspase-3 activity with the speci®c substrate DEVD-AMC (B, C). All the data in (B) and (C) are presented as means T SD of three replicates of a representative experiment; essentially the same results were obtained in three independent experiments. observed in primary skin ®broblasts. Immunoblot analysis was performed using antibodies that recognize both the full-length (113 kDa) and 89 kDa cleavage products of PARP. Although PARP is degraded at the higher doses of SM, no apoptotic cleavage fragments were observed (Fig 1A) . Instead, PARP was cleaved into a 50 kDa fragment, which has been previously reported to be a major cleavage product diagnostic of necrotic cell death (Shah et al, 1996) . As expected, no immunodetectable PARP was observed in the PARP ±/± ®broblasts, con®rming the PARP ±/± genotype. The puri®cation and characterization of caspase-3, responsible for the cleavage of PARP during apoptosis, was performed by Nicholson et al (1995) . This enzyme is composed of two subunits of 17 and 12 kDa that are derived from a common proenzyme, which is related to interleukin-1b-converting enzyme and to CED-3, the product of a gene required for programmed cell death in Caenorhabditis elegans (Yuan et al, 1993) . The identity of this protease was also demonstrated by Tewari et al (1995) . Twentyfour hours after exposure, extracts were derived and analyzed for caspase-3 activity using a¯uorometric assay (Materials and Methods). Whereas PARP +/+ primary ®broblasts did not exhibit SM-induced caspase activity at any of the doses tested, PARP ±/± ®broblasts exhibited marked caspase-3 activity in response to SM at all doses tested (Fig 1B) . The greatest caspase-3 activity was observed following treatment of PARP ±/± ®broblasts with 300 mM SM. Thus, PARP appears to inhibit apoptosis in primary dermal ®broblasts.
To determine if the difference in SM-induced caspase-3 activity was time dependent, we performed a time course experiment. PARP ±/± or PARP +/+ primary skin ®broblasts were exposed to 300 mM SM, and then harvested at different time increments and assayed for caspase-3 activity. Figure 1(C) shows that, at all time points, PARP ±/± cells displayed substantially more caspase-3 activity than PARP +/+ cells.
To con®rm that the difference in the mode of cell death in SMexposed PARP ±/± and PARP +/+ skin ®broblasts was associated with a difference in processing of procaspase-3 into its catalytically active form, an immunoblot analysis was performed, using an antibody speci®c for the larger subunits (p17/p20) of active caspase-3. Figure 2(A) shows that SM induces the cleavage of procaspase-3 into the active p17/p20 forms in skin ®broblasts derived from PARP ±/± but not PARP +/+ mice. To further establish the modes of cell death induced by SM in PARP ±/± versus PARP +/+ skin ®broblasts, we analyzed the pattern of genomic DNA fragmentation following exposure to SM. Following SM exposure DNA was isolated from the two different cell types and analyzed by agarose gel electrophoresis, followed by ethidium bromide staining. Figure 2(B) shows that DNA isolated from SM-exposed PARP ±/± primary skin ®broblasts demonstrated the characteristic apoptotic pattern of internucleosomal cleavage, whereas PARP +/+ ®broblast DNA appeared as a smear, characteristic of necrosis.
An early marker of apoptosis is the exposure of phosphatidylserine residues in the outer plasma membrane lea¯et (Fadok et al, 1992) . The presence of these residues can be detected by their ability to bind to annexin V (Koopman et al, 1994 ). To further examine the level of apoptosis in these primary dermal ®broblasts, we therefore exposed cells to increasing doses of SM and then analyzed the cells for annexin V binding by FACS analysis 24 h after SM exposure. Whereas only a small percentage of PARP +/+ primary ®broblasts were apoptotic at all doses of SM tested (< 20%), a dose-dependent increase in the number of PARP ±/± apoptotic ®broblasts was observed, up to a maximum of 80% (Fig 3A, left) .
These results suggested that the absence of PARP shifted the mode of cell death from necrosis to apoptosis. To verify if this is the case, we examined the percentage of cells that were positive for PI staining and were also annexin V negative, indicating a primarily necrotic mode of cell death. PARP +/+ primary ®broblasts exhibited a dose-dependent increase in the level of necrosis, whereas PARP ±/± ®broblasts underwent little necrosis at all doses tested (Fig 3A, right) . In a separate set of experiments, we con®rmed the mode of cell death induced by SM in wildtype and PARP ±/± dermal ®broblasts, using annexin V plus PI staining. Figure 3 (B) clearly shows that the primary mode of cell death in PARP +/+ cells is necrotic, whereas PARP ±/± cells undergo apoptosis.
In view of the absence of PARP-induced caspase-3 activity and apoptosis in SM-exposed PARP ±/± ®broblasts, we examined whether caspase-3 was in fact responsible for SM cytotoxicity in PARP ±/± cells. We therefore preincubated PARP ±/± cells with either an inhibitor of caspase-3 (DEVD-CHO) or caspase-1 (YVAD-CHO) for 30 min prior to and during SM exposure. PARP ±/± ®broblasts that were either not pretreated or pretreated with YVAD-CHO underwent apoptosis following SM exposure (Fig 3C) . Pretreatment with DEVD-CHO abolished the apoptotic response, however. Thus the deletion of PARP leads to an apoptotic mode of death that is dependent on caspase-3.
To more ®rmly establish the role of PARP in the mode of cell death in ®broblasts, we utilized immortalized PARP ±/± ®broblasts that were stably transfected with human PARP-1 cDNA or with empty vector alone. Western analysis shows that PARP is expressed in immortalized wildtype ®broblasts (PARP +/+ ), as well as PARP ±/± ®broblasts stably transfected with the human PARP cDNA [PARP ±/± (+PARP)], but not in immortalized PARP ±/± ®broblasts ( Fig 4A) . PARP ±/± or PARP ±/± (+PARP) ®broblasts were then exposed to similar concentrations of SM and analyzed for caspase-3 activity by performing an in vitro PARP cleavage assay (Materials and Methods). PARP cleavage activity was induced in PARP ±/± ®broblasts at SM doses greater than 100 mM, with > 60% cleavage observed at the highest dose of SM tested (500 mM; Fig 4B) . In contrast, the reintroduction of PARP suppressed the in vitro PARP cleavage activity, suggesting that expression of PARP rendered these cells more susceptible to necrosis. To further analyze Figure 2 . Exposure of primary dermal ®broblast cells derived from PARP ±/± but not PARP +/+ mice results in proteolytic processing of procaspase-3 and internucleosomal DNA fragmentation. Primary dermal ®broblasts were derived from newborn mice as described in Materials and Methods. Cells were incubated for 24 h with the indicated concentrations of SM in keratinocyte growth medium, after which whole cell extracts (A), or DNA (B), were prepared and assayed for proteolytic cleavage of caspase-3 by immunoblot analysis (A) or DNA fragmentation by agarose gel electrophoresis (B).
caspase-3 processing, cells were exposed to SM and analyzed for the correct processing of procaspase-3 (32 kDa) into its active form (p17). Caspase-3 processing can clearly be observed at 300 mM and 500 mM SM in the PARP ±/± cells but not in the cells stably retransfected with PARP cDNA (Fig 4C) .
To analyze the level of apoptosis after reintroduction of PARP, annexin V plus PI staining was again utilized. Both PARP +/+ and PARP ±/± (+PARP) immortalized ®broblasts showed only low levels of annexin V staining at all doses of SM tested (<5%; Fig 5A) . On the other hand, immortalized PARP ±/± ®broblasts demonstrated a dose-dependent increase in annexin-V-positive cells, up to a maximum of 22%, corresponding to exposure to 500 mM SM. Conversely, dose-dependent increases in PI-positive cells were observed in both PARP +/+ and PARP ±/± (+PARP) cells, but not in PARP ±/± cells, indicating that the expression of PARP increases the level of necrosis in immortalized ®broblasts.
SM induces apoptosis in keratinocytes in the presence or absence of PARP We next assessed the role of PARP in the induction of apoptosis in keratinocytes. Primary mouse keratinocytes derived from PARP ±/± animals grow poorly under culture conditions that we normally use. In order to obtain a suf®cient supply of keratinocytes, we derived keratinocyte clones from PARP ±/± and PARP +/+ animals following immortalization of cells with a retrovirus that expresses both the E6 and E7 genes of HPV 16. A number of clones were found to be both keratinpositive and vimentin-negative by Western analysis, indicating that these cells were in fact keratinocytes and not ®broblasts (Fig 6A,  middle and bottom panels) . As with all other cells utilized in the study, these clones were also con®rmed to be either PARP ±/± or PARP +/ + by immunoblot analysis (Fig 6A, top panel) . Two different clones of each type were then exposed to SM and caspase-3-like activity was determined by a¯uorometric assay as described above. All clones demonstrated a very strong apoptotic response to SM (Fig 6B) . At the lower dose (100 mM), there was no signi®cant difference observed in the level of caspase-3 activity induced by SM, whereas at the higher dose (300 mM), extracts from the PARP ±/± keratinocytes showed a slightly higher activity. Furthermore, in contrast to ®broblasts, patterns of PARP and caspase-3 cleavage in keratinocytes indicated an apoptotic response (Fig 6C, D) . Thus, SM induces apoptosis in keratinocytes both in the presence and in the absence of PARP. DISCUSSION SM vesication clearly involves both cytotoxicity and detachment of the epidermal basal layer in vivo. Using a cell culture model in this study, we have described two potential mechanisms for SMinduced keratinocyte basal cell death and detachment: induction of necrosis in dermal ®broblasts and apoptosis in keratinocytes. As the primary target of SM is the skin, we derived primary skin ®broblasts from PARP +/+ or PARP ±/± newborn animals to determine the contribution of PARP to SM toxicity. Using quantitativē uorometric assays, primary skin ®broblasts from PARP-de®cient mice showed increased caspase-3 activity compared to those derived from PARP +/+ animals. Consistent with this observation, in PARP ±/± skin ®broblasts, SM induced proteolytic processing of procaspase-3 to its active form, and apoptotic internucleosomal cleavage of genomic DNA. In contrast, PARP +/+ cells displayed characteristic markers of necrosis upon exposure to SM; PARP was cleaved to a 50 kDa fragment, no caspase-3 processing was evident, and genomic DNA displayed random fragmentation. Furthermore, FACS analysis with annexin V revealed no binding to PARP +/+ cells compared to cells derived from PARP ±/± animals. PI staining also revealed that PARP shifted the mode of cell death from apoptosis to necrosis. We also utilized immortalized PARP ±/± ®broblasts transfected with vector alone or with PARP cDNA. In vitro PARP cleavage assays as well as immunoblot analysis revealed that only the PARP ±/± cells displayed markers of apoptosis in response to SM exposure. Primary keratinocytes were also derived from newborn PARP +/+ and PARP ±/± mice, and immortalized with the E6 and E7 genes of HPV. In contrast to ®broblasts, keratinocytes from both types of mice express markers of apoptosis in response to SM exposure, consistent with our earlier studies with normal human epidermal keratinocytes .
SM induces both epidermal cell death and detachment from the basal lamina in vivo. The modes of cell death of keratinocytes and ®broblasts both contribute to SM vesication as detachment may be the result of the release of basal lamina-degrading cytosolic components during dermal ®broblast necrosis (Lindsay and Upshall, 1995; Gentilhomme et al, 1998) , whereas keratinocyte basal cell death is primarily due to apoptosis at the doses tested . The mode of cell death induced by SM probably also affects the levels of cytokines and other factors that determine the severity of the in¯ammatory response, as well as the time required for healing. For example, SM-pretreated dermal ®broblasts were shown to exert inhibitory effects on the adhesion and maturation of SM-untreated keratinocytes (Gentilhomme et al, 1998) .
Although no in-depth study has been performed previously to determine the mode of cell death induced by SM in skin ®broblasts, this study indicates that these cells undergo necrosis at all concentrations of SM tested (100±500 mM). Several investigators have examined the mode of cell death induced by SM in other cell types. SM induces an apoptotic response in HeLa cells (10± 100 mM; Sun et al, 1999) , peripheral blood lymphocytes (6± 300 mM; Meier and Millard, 1998) , keratinocytes (50±300 mM; Rosenthal et al, 1998; Sto Èppler et al, 1998) , and endothelial cells (< 250 mM; Dabrowska et al, 1996) . A time-dependent shift to necrosis was observed in SM-treated lymphocytes, however (Meier and Millard, 1998) , whereas markers of necrosis were observed at higher levels of SM in endothelial cells (>500 mM; Dabrowska et al, 1996) and HeLa (1 mM; Sun et al, 1999) . , or PARP ±/± (+PARP) ®broblasts were incubated for 24 h with the indicated concentrations of SM in keratinocyte growth medium, after which cells were prepared and assayed for annexin V binding (A) or PI staining (B) by FACS analysis. All the data in panels A and B are presented as means T SD of three replicates of a representative experiment; essentially the same results were obtained in three independent experiments. SM is a strong bifunctional alkylating agent with a high af®nity for DNA, and has been shown to induce DNA strand breaks and consequently activate PARP within 2 h of exposure Hinshaw et al, 1999) . It is therefore likely that DNA strand breaks and the activation of PARP play a role in the SM-induced cell death in dermal ®broblasts and keratinocytes. The potential role of PARP in determining the role of cell death has been examined with SM-exposed peripheral blood lymphocytes, in which inhibition of necrotic but not apoptotic markers was observed when cells were treated with PARP inhibitors (Meier and Millard, 1998) . These results are consistent with those of this study, which indicate that the absence of PARP in skin ®broblasts shifts the mode of cell death from necrosis to apoptosis. Also consistent with the results of this study, our preliminary studies in which newborn wildtype and PARP-de®cient mice have been exposed to SM by vapor cup indicate that PARP modulates the response of intact animals as well (Rosenthal et al, manuscript in preparation) . The mechanisms that underlie the differences in the modes of cell death in these two cell types remain to be elucidated, but may either be directly related to the levels or activity of PARP in these cells, or result from other events that regulate cellular NAD and ATP levels.
PARP inhibitors have been shown to extend the lifespan of lymphocytes treated with SM (Meier and Johnson, 1992; Meier, 1996) , and inhibitors of PARP have been reported to signi®cantly affect the extent of apoptosis in response to other agents (Rice et al, 1992; Ghibelli et al, 1994; Monti et al, 1994; Kuo et al, 1996) . PARP may thus be an important signaling molecule for cell death either via the lowering of NAD and/or ATP levels (Wielckens et al, 1982; Berger et al, 1983; Alvarez et al, 1986) , or by poly(ADPribosyl)ation of other key cellular proteins, such as p53 (Whitacre et al, 1995; Simbulan-Rosenthal et al, 1999) and the Ca 2+ /Mg 2+ -dependent nuclease involved in the apoptotic cleavage of DNA (Rice et al, 1992) . Depletion of cellular NAD and ATP levels via PARP activation can contribute to either apoptotic or necrotic cell death, as partial depletion of ATP induces apoptosis (Feldenberg et al, 1999) , whereas depletion of ATP below a threshold level blocks the later events in apoptosis (Eguchi et al, 1999) , thereby shunting the mode of cell death to necrosis.
An understanding of the mechanisms for SM-induced cell death in keratinocytes and dermal ®broblasts will hopefully lead to strategies for prevention or treatment of SM vesication. This study suggests that inhibition of PARP (upstream) or caspase-3 (downstream) may alter the response of the epidermis to SM. PARP inhibitors have already been successfully employed in the prevention of tissue damage in other models, including diabetes (Masiello et al, 1985) , ischemia (Endres et al, 1997; Takahashi et al, 1999) , and arthritis (Szabo et al, 1998) , and may prove effective for SM as well, either alone or in combination with caspase-3 inhibitors. Figure 6 . SM induces caspase-3 activity in different clones of both PARP ±/± and PARP +/+ cells. Primary keratinocytes were derived from PARP +/+ or PARP ±/± newborn mice and immortalized with the E6 and E7 genes of HPV 16 as described in Materials and Methods. Cell extracts were subjected to immunoblot analysis using antibodies speci®c for PARP (A, top), vimentin (A, middle), or cytokeratin (A, bottom). Representative clones of PARP ±/± or PARP +/+ keratinocytes were incubated for 24 h with the indicated concentrations of SM in keratinocyte growth medium, after which whole cell extracts were subjected to caspase-3 activity assays with the speci®c substrate DEVD-AMC (B), or immunoblot analysis using antibodies speci®c for caspase-3 (C), or PARP (D). Bars in (B) represent the range of average activities for two different clones.
